Antonio Macrì, Department of Human Pathology, General Surgery Unit, University of Messina, 98125 Messina, Italy.
World J Gastrointest Oncol. 2010 Jan 15;2(1):9-11. doi: 10.4251/wjgo.v2.i1.9.
Peritoneal surface malignancies (PSM) are a clinical entity with an unfavourable prognosis. They comprise peritoneal carcinomatosis, pseudomyxoma peritonei, and primitive tumors of the peritoneum. Because the treatment of PSM presents unique and challenging problems to the cancer clinician, many new approaches have been attempted in recent years. In the current and next issues of World Journal of Gastrointestinal Oncology, some international groups of researchers discuss the most important and innovative aspects of PSM treatment, with particular accuracy for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. In conclusion, because this new approach to PSM has a reputation for being based more on common sense than on experimental data, I hope that highlighting this topic can make a contribution to the treatment of this group of diseases.
腹膜表面恶性肿瘤（PSM）是一种预后不良的临床实体。它们包括腹膜癌、假性黏液瘤和腹膜原始肿瘤。由于 PSM 的治疗给癌症临床医生带来了独特而具有挑战性的问题，近年来尝试了许多新方法。在本期和下期的《世界胃肠肿瘤学杂志》中，一些国际研究小组讨论了 PSM 治疗的最重要和最具创新性的方面，特别是针对细胞减灭术和腹腔热灌注化疗。总之，由于这种治疗 PSM 的新方法似乎更多地基于常识而不是实验数据，我希望强调这个话题能够为治疗这组疾病做出贡献。
